NCT03460730View on ClinicalTrials.gov

Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 4, 2004

Primary Completion Date

July 3, 2006

Study Completion Date

July 3, 2006

Conditions
Pneumonia, Pneumococcal
Interventions
BIOLOGICAL

Pneumovax

23-valent pneumococcal polysaccharide vaccine

Trial Locations (1)

Unknown

Kilifi District Hospital, Kilifi

All Listed Sponsors
lead

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

NCT03460730 - Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax) | Biotech Hunter | Biotech Hunter